| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Dawes Karen A is a Director at REPLIGEN CORP with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 48 sells.
Estimated insider holdings value: $11.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | RGEN Repligen Corp | Director | Sell | 275 | $161.00 | $44,275.00 | -0.3% | -24.0% | - | |
| Feb 27, 2024 | RGEN Repligen Corp | Director | Sale+OE | 1,000 | $193.35 | $193,350.00 | -1.1% | -18.7% | -15.5% | |
| Aug 29, 2023 | RGEN Repligen Corp | Director | Sale+OE | 850 | $171.38 | $145,673.00 | -1.0% | -7.3% | -15.5% | |
| Sep 9, 2022 | RGEN Repligen Corp | Director | Sell | 775 | $227.17 | $176,056.75 | -1.0% | -25.6% | -30.9% | |
| May 25, 2022 | RGEN Repligen Corp | Director | Sell | 14,715 | $150.51 | $2,214,819.39 | -3.5% | +45.3% | +8.9% | |
| Nov 10, 2021 | RGEN Repligen Corp | Director | Sale+OE | 4,783 | $263.93 | $1,262,354.72 | -0.5% | -27.3% | -28.3% | |
| Nov 2, 2021 | RGEN Repligen Corp | Director | Sell | 2,400 | $303.94 | $729,466.65 | -0.4% | -34.5% | -43.3% | |
| Sep 14, 2021 | RGEN Repligen Corp | Director | Sell | 274 | $294.26 | $80,628.12 | - | -12.2% | -22.9% | |
| Sep 1, 2021 | RGEN Repligen Corp | Director | Sale+OE | 3,459 | $283.91 | $982,057.54 | -0.6% | +0.2% | -25.2% | |
| Aug 18, 2021 | RGEN Repligen Corp | Director | Sell | 18,956 | $254.18 | $4,818,219.37 | -1.7% | +5.6% | -5.3% |